Peng Dai

Person

Auburndale, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 11,958,879
- Issue date Apr 16, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 11,718,641
- Issue date Aug 8, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 11,040,998
- Issue date Jun 22, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 10,968,249
- Issue date Apr 6, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparation of sulfonylurea bile acid derivatives
- Patent number 10,947,264
- Issue date Mar 16, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 10,696,713
- Issue date Jun 30, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparation of sulfonylurea bile acid derivatives
- Patent number 10,584,145
- Issue date Mar 10, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid analogs as FXR/TGR5 agonists and methods of use thereof
- Patent number 10,519,191
- Issue date Dec 31, 2019
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR agonists and methods of use thereof
- Patent number 10,472,386
- Issue date Nov 12, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 10,457,703
- Issue date Oct 29, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Deuterated bile acid derivatives as FXR/TGR5 agonists and methods o...
- Patent number 10,364,267
- Issue date Jul 30, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 10,208,081
- Issue date Feb 19, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof
- Publication number 20240327452
- Publication date Oct 3, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20240140984
- Publication date May 2, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20220402966
- Publication date Dec 22, 2022
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof
- Publication number 20210261600
- Publication date Aug 26, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20200347092
- Publication date Nov 5, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR PREPARATION OF SULFONYLUREA BILE ACID DERIVATIVES
- Publication number 20200247839
- Publication date Aug 6, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20200109164
- Publication date Apr 9, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20190194245
- Publication date Jun 27, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BILE ACID DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20180237471
- Publication date Aug 23, 2018
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR PREPARATION OF SULFONYLUREA BILE ACID DERIVATIVES
- Publication number 20180148469
- Publication date May 31, 2018
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DEUTERATED BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS O...
- Publication number 20170240585
- Publication date Aug 24, 2017
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20160289262
- Publication date Oct 6, 2016
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20160185815
- Publication date Jun 30, 2016
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof
- Publication number 20160176917
- Publication date Jun 23, 2016
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BILE ACID ANALOGS AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20160145296
- Publication date May 26, 2016
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Process for preparation of sulfonylurea bile acid derivatives

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Process for preparation of sulfonylurea bile acid derivatives

Bile acid analogs as FXR/TGR5 agonists and methods of use thereof

Bile acid derivatives as FXR agonists and methods of use thereof

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Deuterated bile acid derivatives as FXR/TGR5 agonists and methods o...

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Patents Applicationslast 30 patents

Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof

BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF

BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF

Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof

BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF

PROCESS FOR PREPARATION OF SULFONYLUREA BILE ACID DERIVATIVES

BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF

BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF

BILE ACID DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF

PROCESS FOR PREPARATION OF SULFONYLUREA BILE ACID DERIVATIVES

DEUTERATED BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS O...

BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF

BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF

Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof

BILE ACID ANALOGS AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF